{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T19:19:53Z","timestamp":1790623193825,"version":"4.1.0"},"reference-count":124,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,3,17]],"date-time":"2022-03-17T00:00:00Z","timestamp":1647475200000},"content-version":"am","delay-in-days":381,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Advanced Drug Delivery Reviews"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/j.addr.2020.09.002","type":"journal-article","created":{"date-parts":[[2020,9,9]],"date-time":"2020-09-09T21:18:02Z","timestamp":1599686282000},"page":"340-352","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":66,"special_numbering":"C","title":["In vitro \u2013 in vivo correlation of intranasal drug deposition"],"prefix":"10.1016","volume":"170","author":[{"given":"S.","family":"Le Guellec","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Ehrmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Vecellio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl. 1","key":"10.1016\/j.addr.2020.09.002_bb0005","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1089\/jam.2007.0569","article-title":"Devices for aerosol delivery to treat sinusitis","volume":"20","author":"Laube","year":"2007","journal-title":"J. Aerosol. Med."},{"key":"10.1016\/j.addr.2020.09.002_bb0010","doi-asserted-by":"crossref","first-page":"288","DOI":"10.18433\/J3NC79","article-title":"Intranasal drug delivery: how, why and what for?","volume":"12","author":"Pires","year":"2009","journal-title":"J. Pharm. Pharm. Sci."},{"key":"10.1016\/j.addr.2020.09.002_bb0015","doi-asserted-by":"crossref","first-page":"566","DOI":"10.2174\/156720112803529828","article-title":"Anatomical and histological factors affecting intranasal drug and vaccine delivery","volume":"9","author":"Gizurarson","year":"2012","journal-title":"Curr. Drug Deliv."},{"key":"10.1016\/j.addr.2020.09.002_bb0020","doi-asserted-by":"crossref","first-page":"709","DOI":"10.4155\/tde.14.41","article-title":"The nasal approach to delivering treatment for brain diseases: an anatomic, physiologic, and delivery technology overview","volume":"5","author":"Djupesland","year":"2014","journal-title":"Ther. Deliv."},{"key":"10.1016\/j.addr.2020.09.002_bb0025","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1089\/jamp.2019.1524","article-title":"Nasal high-flow nebulization for lung drug delivery: theoretical, experimental, and clinical application","volume":"32","author":"Dugernier","year":"2019","journal-title":"J. Aerosol. Med. Pulm. Drug Deliv."},{"key":"10.1016\/j.addr.2020.09.002_bb0030","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1046\/j.1365-2273.2003.00707.x","article-title":"The impact of expiration on particle deposition within the nasal cavity","volume":"28","author":"Wiesmiller","year":"2003","journal-title":"Clin. Otolaryngol. Allied Sci."},{"key":"10.1016\/j.addr.2020.09.002_bb0035","series-title":"Guideline on the Pharmaceutical Quality of Inhalation and Nasal Products","year":"2006"},{"key":"10.1016\/j.addr.2020.09.002_bb0040","series-title":"Nasal Spray and Inhalation Solution, Suspension, and Spray Drug Products--Chemistry, Manufacturing, and Controls Documentation Guidance for Industry","author":"Guidance Document","year":"2002"},{"key":"10.1016\/j.addr.2020.09.002_bb0045","series-title":"European Pharmacopoeia","first-page":"1763","author":"Nasal Preparations\/Nasalia","year":"1997"},{"key":"10.1016\/j.addr.2020.09.002_bb0050","series-title":"Guidance document","author":"Bioavailability and Bioequivalence Studies for Nasal Aerosols and Nasal Sprays for Local Action","year":"2003"},{"key":"10.1016\/j.addr.2020.09.002_bb0055","doi-asserted-by":"crossref","first-page":"3122","DOI":"10.1007\/s11095-012-0804-7","article-title":"Measurement of drug in small particles from aqueous nasal sprays by Andersen Cascade impactor","volume":"29","author":"Doub","year":"2012","journal-title":"Pharm. Res."},{"key":"10.1016\/j.addr.2020.09.002_bb0060","doi-asserted-by":"crossref","first-page":"3723","DOI":"10.1208\/s12249-018-1179-9","article-title":"Evaluation of nasal inlet ports having simplified geometry for the pharmacopeial assessment of mass fraction of dose likely to penetrate beyond the nasopharynx: a preliminary investigation","volume":"19","author":"Williams","year":"2018","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.addr.2020.09.002_bb0065","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1089\/jamp.2018.1473","article-title":"Analytical challenges of spray pattern method development for purposes of In vitro bioequivalence testing in the case of a nasal spray product","volume":"32","author":"Grma\u0161","year":"2019","journal-title":"J. Aerosol. Med. Pulm. Drug Deliv."},{"key":"10.1016\/j.addr.2020.09.002_bb0070","doi-asserted-by":"crossref","first-page":"195","DOI":"10.3390\/pharmaceutics6020195","article-title":"Analytical challenges and regulatory requirements for nasal drug products in Europe and the U.S","volume":"6","author":"Trows","year":"2014","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.addr.2020.09.002_bb0075","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1002\/jps.20678","article-title":"The influence of actuation parameters on in vitro testing of nasal spray products","volume":"9","author":"Guo","year":"2006","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.addr.2020.09.002_bb0080","series-title":"Applications for Droplet Sizing. Manual versus Automated Actuation of Nasal Sprays, Pharmaceutical Technology","first-page":"30","author":"Kippax","year":"2004"},{"key":"10.1016\/j.addr.2020.09.002_bb0085","doi-asserted-by":"crossref","first-page":"711","DOI":"10.3109\/03639045.2013.777735","article-title":"Automated actuation of nasal spray products: effect of hand-related variability on the in vitro performance of Flonase nasal spray","volume":"40","author":"Doughty","year":"2014","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.addr.2020.09.002_bb0090","first-page":"4","article-title":"Influence of the human factor on nasal drug delivery device evaluation","volume":"85","author":"Farjas","year":"2018","journal-title":"ONdrugDeliv. Magazine."},{"key":"10.1016\/j.addr.2020.09.002_bb0095","series-title":"Scientific Considerations for the Review and Approval of First Generic Mometasone Furoate Nasal Suspension Spray in the United States from the Bioequivalence Perspective","first-page":"14","volume":"21","author":"Liu","year":"2019"},{"key":"10.1016\/j.addr.2020.09.002_bb0100","series-title":"Anaesthetic and Respiratory Equipment - Nebulizing Systems and Components","author":"EN ISO 27427","year":"2013"},{"key":"10.1016\/j.addr.2020.09.002_bb0105","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.ijpharm.2018.06.058","article-title":"A modified USP induction port to characterize nasal spray plume geometry and predict turbinate deposition under flow","volume":"548","author":"Moraga-Espinoza","year":"2018","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.addr.2020.09.002_bb0110","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1208\/s12249-011-9594-1","article-title":"Assessment of the influence factors on nasal spray droplet velocity using phase-Doppler anemometry (PDA)","volume":"12","author":"Liu","year":"2011","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.addr.2020.09.002_bb0115","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1089\/jamp.2013.1093","article-title":"Measurements of droplet size distribution and analysis of nasal spray atomization from different actuation pressure","volume":"28","author":"Inthavong","year":"2015","journal-title":"J. Aerosol. Med. Pulm. Drug Deliv."},{"key":"10.1016\/j.addr.2020.09.002_bb0120","series-title":"(Librairie Arnette) La Physiologie des Sinues et ses Applications Cliniques et Th\u00e9rapeutiques, Societe fran\u00e7aise D\u2019otorhinolaryngologie","first-page":"522","article-title":"Les aerosols","author":"Badre","year":"1959"},{"key":"10.1016\/j.addr.2020.09.002_bb0125","first-page":"1097","article-title":"A new method of aerosol penetration into the sinuses","volume":"67","author":"Guillerm","year":"1959","journal-title":"Presse Med."},{"key":"10.1016\/j.addr.2020.09.002_bb0130","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1152\/jappl.1985.59.6.1766","article-title":"Aerosol deposition in the airway with excessive mucus","volume":"59","author":"Kim","year":"1985","journal-title":"J. Appl. Physiol."},{"key":"10.1016\/j.addr.2020.09.002_bb0135","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1183\/09031936.03.00017903","article-title":"Assessment of nasal and sinus nitric oxide output using single-breath humming exhalations","volume":"22","author":"Maniscalco","year":"2003","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.addr.2020.09.002_bb0140","first-page":"221","article-title":"In vitro study of sonic aerosol to maxillary sinuses treatment","volume":"19","author":"Durand","year":"2006","journal-title":"Drug Deliv. Lung."},{"key":"10.1016\/j.addr.2020.09.002_bb0145","first-page":"213","article-title":"Ventilation and drug delivery to the paranasal sinuses: studies in a nasal cast using pulsating airflow","volume":"46","author":"M\u00f6ller","year":"2008","journal-title":"Rhinology"},{"key":"10.1016\/j.addr.2020.09.002_bb0150","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.otohns.2009.12.028","article-title":"Pulsating aerosols for drug delivery to the sinuses in healthy volunteers","volume":"142","author":"M\u00f6ller","year":"2010","journal-title":"Otolaryngol. Head Neck Surg."},{"key":"10.1016\/j.addr.2020.09.002_bb0155","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1007\/s00330-012-2483-5","article-title":"Ventilation imaging of the paranasal sinuses using xenon-enhanced dynamic single-energy CT and dual-energy CT: a feasibility study in a nasal cast","volume":"22","author":"Thieme","year":"2012","journal-title":"Eur. Radiol."},{"key":"10.1016\/j.addr.2020.09.002_bb0160","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1152\/japplphysiol.00934.2014","article-title":"Nasal high flow clears anatomical dead space in upper airway models","volume":"118","author":"M\u00f6ller","year":"2015","journal-title":"J. Appl. Physiol."},{"key":"10.1016\/j.addr.2020.09.002_bb0165","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.ijpharm.2017.02.017","article-title":"Understanding the mechanisms underlying pulsating aerosol delivery to the maxillary sinus: In vitro tests and computational simulations","volume":"30","author":"Xi","year":"2017","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.addr.2020.09.002_bb0170","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1093\/oxfordjournals.rpd.a081068","article-title":"Inspiratory inertial deposition of aerosols in human nasal airway replicate casts: implication for the proposed NCRP lung model","volume":"38","author":"Swift","year":"1991","journal-title":"Radiat. Prot. Dosim."},{"key":"10.1016\/j.addr.2020.09.002_bb0175","first-page":"69","article-title":"Construction of a model of human nasal airways using in vivo morphometric data","volume":"38","author":"Guilmette","year":"1994","journal-title":"Ann. Occup. Hyg."},{"key":"10.1016\/j.addr.2020.09.002_bb0180","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1089\/08942680152484199","article-title":"Characterization of nasal spray pumps and deposition pattern in a replica of the human nasal airway","volume":"14","author":"Cheng","year":"2001","journal-title":"J. Aerosol. Med."},{"key":"10.1016\/j.addr.2020.09.002_bb0185","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1089\/jam.2007.0638","article-title":"The influence of spray properties on intranasal deposition","volume":"20","author":"Foo","year":"2007","journal-title":"J. Aerosol Med. Depos. Clear. Eff. Lung"},{"key":"10.1016\/j.addr.2020.09.002_bb0190","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1080\/027868290883360","article-title":"Particle deposition in human nasal airway replicas manufactured by different methods. Part I: inertial regime particles","volume":"38","author":"Kelly","year":"2004","journal-title":"Aerosol Sci. Technol."},{"key":"10.1016\/j.addr.2020.09.002_bb0195","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1007\/s11095-009-0002-4","article-title":"Assessment of nasal spray deposition pattern in a silicone human nose model using a color-based method","volume":"27","author":"Kundoor","year":"2010","journal-title":"Pharm. Res."},{"key":"10.1016\/j.addr.2020.09.002_bb0200","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1007\/s11095-011-0417-6","article-title":"Effect of formulation- and administration-related variables on deposition pattern of nasal spray pumps evaluated using a nasal cast","volume":"28","author":"Kundoor","year":"2011","journal-title":"Pharm. Res."},{"key":"10.1016\/j.addr.2020.09.002_bb0205","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1007\/s11095-005-7391-9","article-title":"The effect of formulation variables and breathing patterns on the site of nasal deposition in an anatomically correct model","volume":"22","author":"Guo","year":"2005","journal-title":"Pharm. Res."},{"key":"10.1016\/j.addr.2020.09.002_bb0210","doi-asserted-by":"crossref","first-page":"816","DOI":"10.3109\/03639045.2012.707210","article-title":"Development of in vitro models to demonstrate the ability of PecSys\u00ae, an in situ nasal gelling technology, to reduce nasal run-off and drip","volume":"39","author":"Castile","year":"2013","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.addr.2020.09.002_bb0215","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1016\/j.xphs.2015.12.016","article-title":"Development and evaluation of a novel intranasal spray for the delivery of amantadine","volume":"105","author":"Lungare","year":"2016","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.addr.2020.09.002_bb0220","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.ijpharm.2019.04.015","article-title":"Innovative sprayable in situ gelling fluticasone suspension: development and optimization of nasal deposition","volume":"536","author":"Ni\u017ei\u0107","year":"2019","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.addr.2020.09.002_bb0225","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1243\/09544119JEIM423","article-title":"Development of a nasal cast model to test medicinal nasal devices","volume":"222","author":"Hughes","year":"2008","journal-title":"Proc. Inst. Mech. Eng. H"},{"key":"10.1016\/j.addr.2020.09.002_bb0230","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1089\/jamp.2012.1011","article-title":"Design of experiments to optimize an in vitro cast to predict human nasal drug deposition","volume":"27","author":"Shah","year":"2014","journal-title":"J. Aerosol Med. Pulm. Drug Deliv."},{"key":"10.1016\/j.addr.2020.09.002_bb0235","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.jconrel.2008.11.009","article-title":"Development and testing of particulate formulations for the nasal delivery of antibodies","volume":"135","author":"Kaye","year":"2009","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2020.09.002_bb0240","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.jaerosci.2012.07.013","article-title":"An idealized geometry that mimics average infant nasal airway deposition","volume":"55","author":"Javaheri","year":"2013","journal-title":"J. Aerosol Sci."},{"key":"10.1016\/j.addr.2020.09.002_bb0245","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1089\/jamp.2013.1084","article-title":"Experimental measurements and computational predictions of regional particle deposition in a sectional nasal model","volume":"28","author":"Schroeter","year":"2015","journal-title":"J. Aerosol Med. Pulm. Drug Deliv."},{"key":"10.1016\/j.addr.2020.09.002_bb0250","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1007\/s11095-016-1896-2","article-title":"Visualization and quantification of nasal and olfactory deposition in a sectional adult nasal airway cast","volume":"33","author":"Xi","year":"2016","journal-title":"Pharm. Res."},{"key":"10.1016\/j.addr.2020.09.002_bb0255","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.carbpol.2017.01.044","article-title":"Formulation of olfactory-targeted microparticles with tamarind seed polysaccharide to improve nose-to-brain transport of drugs","volume":"163","author":"Yarragudi","year":"2017","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.addr.2020.09.002_bb0260","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.ijpharm.2017.08.079","article-title":"Powder aerosol delivery through nasal high-flow system: in vitro feasibility and influence of process conditions","volume":"533","author":"Okuda","year":"2017","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.addr.2020.09.002_bb0265","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1089\/jamp.2016.1295","article-title":"Nasal and olfactory deposition with Normal and bidirectional intranasal delivery techniques: in vitro tests and numerical simulations","volume":"30","author":"Xi","year":"2017","journal-title":"J. Aerosol Med. Pulm. Drug Deliv."},{"key":"10.1016\/j.addr.2020.09.002_bb0270","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1007\/s11095-018-2385-6","article-title":"In vitro assessment of spray deposition patterns in a Pediatric (12 year-old) nasal cavity model","volume":"35","author":"Sawant","year":"2018","journal-title":"Pharm. Res."},{"key":"10.1016\/j.addr.2020.09.002_bb0275","first-page":"11","article-title":"Evaluating simulated patient use in realistic nasal airway models for the in vitro characterization of nasal spray products","author":"Azimi","year":"2018","journal-title":"Inhalation"},{"key":"10.1016\/j.addr.2020.09.002_bb0280","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1021\/acs.molpharmaceut.7b00702","article-title":"Personalized medicine in nasal delivery: the use of patient-specific administration parameters to improve nasal drug targeting using 3D-printed nasal replica casts","volume":"15","author":"Warnken","year":"2018","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.addr.2020.09.002_bb0285","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.jconrel.2019.03.032","article-title":"Characterisation of nasal devices for delivery of insulin to the brain and evaluation in humans using functional magnetic resonance imaging","volume":"302","author":"Wingrove","year":"2019","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2020.09.002_bb0290","series-title":"Exp. Fluids","first-page":"1005","article-title":"Stereoscopic PIV measurements of flow in the nasal cavity with high flow therapy","author":"Spence","year":"2011"},{"key":"10.1016\/j.addr.2020.09.002_bb0295","unstructured":"RDD website https:\/\/www.rddonline.com\/rdd\/rdd.php?sid=105, last accessed on 2020, July 30th 2020."},{"key":"10.1016\/j.addr.2020.09.002_bb0300","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/194589240401800101","article-title":"Particle deposition of therapeutic aerosols in the nose and paranasal sinuses after transnasal sinus surgery: a cast model study","volume":"18","author":"Saijo","year":"2004","journal-title":"Am. J. Rhinol."},{"key":"10.1016\/j.addr.2020.09.002_bb0305","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1089\/08942680152744640","article-title":"The Sophia anatomical infant nose-throat (saint) model: a valuable tool to study aerosol deposition in infants","volume":"14","author":"Janssens","year":"2001","journal-title":"J. Aerosol Med. Depos. Clear. Eff. Lung"},{"key":"10.1016\/j.addr.2020.09.002_bb0310","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1007\/s11095-010-0171-1","article-title":"Deposition of albuterol aerosol generated by pneumatic nebulizer in the Sophia anatomical infant nose-throat (SAINT) model","volume":"27","author":"Laube","year":"2010","journal-title":"Pharm. Res."},{"key":"10.1016\/j.addr.2020.09.002_bb0315","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1002\/ppul.23509","article-title":"Nasal high flow nebulization in infants and toddlers: an in vitro and in vivo scintigraphic study","volume":"52","author":"R\u00e9miniac","year":"2017","journal-title":"Pediatr. Pulmonol."},{"key":"10.1016\/j.addr.2020.09.002_bb0320","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1016\/j.jaerosci.2008.07.011","article-title":"Deposition of micrometer-sized aerosol particles in infant nasal airway replicas","volume":"39","author":"Storey-Bishoff","year":"2008","journal-title":"J. Aerosol Sci."},{"key":"10.1016\/j.addr.2020.09.002_bb0325","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1203\/PDR.0b013e318175dcfa","article-title":"Development of the premature infant nose throat-model (PrINT-Model): an upper airway replica of a premature neonate for the study of aerosol delivery","volume":"64","author":"Minocchieri","year":"2008","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.addr.2020.09.002_bb0330","first-page":"A17","article-title":"Scintigraphic evaluation of the Easynose nasal nebuliser in a nasal cast model","volume":"52","author":"Le Guellec","year":"2013","journal-title":"Drug Deliv. Lung."},{"key":"10.1016\/j.addr.2020.09.002_bb0335","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1007\/s11095-014-1330-6","article-title":"Impact of airborne particle size, acoustic airflow and breathing pattern on delivery of nebulized antibiotic into the maxillary sinuses using a realistic human nasal replica","volume":"31","author":"Leclerc","year":"2014","journal-title":"Pharm. Res."},{"key":"10.1016\/j.addr.2020.09.002_bb0340","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1007\/s11095-015-1851-7","article-title":"A new strategy to improve drug delivery to the maxillary sinuses: the frequency sweep acoustic airflow","volume":"33","author":"El Merhie","year":"2016","journal-title":"Pharm. Res."},{"key":"10.1016\/j.addr.2020.09.002_bb0345","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1007\/s11095-013-1157-6","article-title":"Validation of anatomical models to study aerosol deposition in human nasal cavities","volume":"31","author":"Le Guellec","year":"2014","journal-title":"Pharm. Res."},{"key":"10.1016\/j.addr.2020.09.002_bb0350","first-page":"330","article-title":"In vitro study of aerosol deposition in nasal cavities during inhalation and exhalation","volume":"24","author":"Francis","year":"2013","journal-title":"Respir. Drug Deliv."},{"key":"10.1016\/j.addr.2020.09.002_bb0355","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.ijpharm.2019.02.026","article-title":"How to characterize a nasal product. The state of the art of in vitro and ex vivo specific methods","volume":"561","author":"Salade","year":"2019","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.addr.2020.09.002_bb0360","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s41747-019-0113-6","article-title":"In vitro qualitative and quantitative CT assessment of iodinated aerosol nasal deposition using a 3D-printed nasal replica","volume":"3","author":"Sartoretti","year":"2019","journal-title":"Eur. Radiol. Exp."},{"key":"10.1016\/j.addr.2020.09.002_bb0365","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1089\/jamp.2019.1523","article-title":"In vitro measurement of regional nasal drug delivery with flonase,\u00ae Flonase\u00ae Sensimist,TM and MAD NasalTM in anatomically correct nasal airway replicas of pediatric and adult human subjects","volume":"32","author":"Hosseini","year":"2019","journal-title":"J. Aerosol Med. Pulm. Drug Deliv."},{"key":"10.1016\/j.addr.2020.09.002_bb0370","unstructured":"The University of North Carolina (UNC), School Medicine Website (Chapel Hill), Center for Environmental Medicine, Asthma and Lung Biology, Mucociliary Clearance and Aerosol Research Laboratory; https:\/\/www.med.unc.edu\/cemalb\/mucociliary-clearance\/bench-research-studies. Last accessed on 2020, July 30th 2020."},{"key":"10.1016\/j.addr.2020.09.002_bb0375","unstructured":"2019 CFD Research Corporation, https:\/\/www.cfd-research.com \/products\/nasal-cavity-phantoms\/ last accessed on 2020, july 30th 2020."},{"key":"10.1016\/j.addr.2020.09.002_bb0380","doi-asserted-by":"crossref","first-page":"196","DOI":"10.2500\/ajr.2007.21.2963","article-title":"Deposition of aerosolized particles in the maxillary sinuses before and after endoscopic sinus surgery","volume":"21","author":"Martin","year":"2007","journal-title":"Am. J. Rhinol."},{"key":"10.1016\/j.addr.2020.09.002_bb0385","doi-asserted-by":"crossref","first-page":"395","DOI":"10.2500\/ajr.2008.22.3192","article-title":"Differential deposition of aerosols in the maxillary sinus of human cadavers by particle size","volume":"22","author":"Hilton","year":"2008","journal-title":"Am. J. Rhinol."},{"key":"10.1016\/j.addr.2020.09.002_bb0390","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/4602651","article-title":"Nasal delivery devices: a comparative study on cadaver model","volume":"2019","author":"Moffa","year":"2019","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.addr.2020.09.002_bb0395","doi-asserted-by":"crossref","first-page":"390","DOI":"10.2500\/ajr.2008.22.3191","article-title":"A prospective controlled trial of pulsed nasal nebulizer in maximally dissected cadavers","volume":"22","author":"Valentine","year":"2008","journal-title":"Am. J. Rhinol."},{"issue":"5","key":"10.1016\/j.addr.2020.09.002_bb0400","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1002\/alr.20057","article-title":"Prospective evaluation of aerosol delivery by a powered nasal nebulizer in the cadaver model","volume":"1","author":"Manes","year":"2011","journal-title":"Int. Forum Allerg. Rhinol."},{"key":"10.1016\/j.addr.2020.09.002_bb0405","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1089\/08942680152007936","article-title":"Preliminary study of the deposition of aerosol in the maxillary sinuses using a plastinated model","volume":"14","author":"Durand","year":"2001","journal-title":"J. Aerosol. Med."},{"key":"10.1016\/j.addr.2020.09.002_bb0410","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1007\/s10439-006-9094-8","article-title":"In vitro experiments and numerical simulations of airflow in realistic nasal airway geometry","volume":"34","author":"Croce","year":"2006","journal-title":"Ann. Biomed. Eng."},{"key":"10.1016\/j.addr.2020.09.002_bb0415","doi-asserted-by":"crossref","first-page":"30","DOI":"10.4193\/Rhino09.187","article-title":"Plastinated nasal model: a new concept of anatomically realistic cast","volume":"49","author":"Durand","year":"2011","journal-title":"Rhinology"},{"key":"10.1016\/j.addr.2020.09.002_bb0420","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.ijpharm.2011.09.023","article-title":"Impact of acoustic airflow nebulization on intrasinus drug deposition of a human plastinated nasal cast: new insights into the mechanisms involved","volume":"421","author":"Durand","year":"2011","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.addr.2020.09.002_bb0425","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.ijpharm.2015.08.025","article-title":"Impact of acoustic airflow on intrasinus drug deposition: new insights into the vibrating mode and the optimal acoustic frequency to enhance the delivery of nebulized antibiotic","volume":"494","author":"Leclerc","year":"2015","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.addr.2020.09.002_bb0430","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1089\/jamp.2013.1039","article-title":"Nasal deposition in infants and children","volume":"27","author":"Zhou","year":"2014","journal-title":"J. Aerosol Med. Pulm. Drug Deliv."},{"key":"10.1016\/j.addr.2020.09.002_bb0435","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1111\/j.1365-2362.2006.01654.x","article-title":"Sounding airflow enhances aerosol delivery into the paranasal sinuses","volume":"36","author":"Maniscalco","year":"2006","journal-title":"Eur. J. Clin. Investig."},{"key":"10.1016\/j.addr.2020.09.002_bb0440","first-page":"276","article-title":"Intra-nasal distribution of aerosols with or without vibration","volume":"157","author":"Sato","year":"1981","journal-title":"Z Erkr Atmungsorgane"},{"key":"10.1016\/j.addr.2020.09.002_bb0445","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1002\/lary.24937","article-title":"Effect of three-drug delivery modalities on olfactory function in chronic sinusitis","volume":"125","author":"Reychler","year":"2015","journal-title":"Laryngoscope"},{"key":"10.1016\/j.addr.2020.09.002_bb0450","doi-asserted-by":"crossref","first-page":"2767","DOI":"10.1208\/s12249-018-1031-2","article-title":"A simplified geometric model to predict nasal spray deposition in children and adults","volume":"19","author":"Foo","year":"2018","journal-title":"AAPS Pharm. Sci. Tech."},{"key":"10.1016\/j.addr.2020.09.002_bb0455","doi-asserted-by":"crossref","first-page":"816","DOI":"10.3109\/03639045.2012.707210","article-title":"Development of in vitro models to demonstrate the ability of PecSys\u00ae, an in situ nasal gelling technology, to reduce nasal run-off and drip","volume":"39","author":"Castile","year":"2013","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.addr.2020.09.002_bb0460","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1089\/jamp.2013.1087","article-title":"Effect of facial material softness and applied force on face mask dead volume, face mask seal, and inhaled corticosteroid delivery through an idealized infant replica","volume":"27","author":"Carrigy","year":"2014","journal-title":"J. Aerosol Med. Pulm. Drug Deliv."},{"key":"10.1016\/j.addr.2020.09.002_bb0465","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.ijpharm.2013.12.032","article-title":"Assessing sinus aerosol deposition: benefits of SPECT-CT imaging","volume":"462","author":"Leclerc","year":"2014","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.addr.2020.09.002_bb0470","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1002\/alr.20041","article-title":"Temporospatial quantification of fluorescein-labeled sinonasal irrigation delivery","volume":"1","author":"Bleier","year":"2011","journal-title":"Int. Forum Allergy Rhinol."},{"key":"10.1016\/j.addr.2020.09.002_bb0475","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1007\/s00405-006-0071-5","article-title":"Influence of anatomy and head position on intranasal drug deposition","volume":"263","author":"Merkus","year":"2006","journal-title":"Eur. Arch. Otorhinolaryngol."},{"key":"10.1016\/j.addr.2020.09.002_bb0480","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1111\/j.2042-7158.1985.tb05069.x","article-title":"Intranasal drug delivery by spray and drops","volume":"37","author":"Hardy","year":"1985","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.addr.2020.09.002_bb0485","doi-asserted-by":"crossref","first-page":"117","DOI":"10.2500\/ajra.2014.28.4026","article-title":"Nasal deposition of ciclesonide nasal aerosol and mometasone aqueous nasal spray in allergic rhinitis patients","volume":"28","author":"Emanuel","year":"2014","journal-title":"Am. J. Rhinol. Allergy"},{"key":"10.1016\/j.addr.2020.09.002_bb0490","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1089\/jamp.2011.0924","article-title":"Nasal deposition and clearance in man: comparison of a bidirectional powder device and a traditional liquid spray pump","volume":"280","author":"Djupesland","year":"2012","journal-title":"J. Aerosol. Med. Pulm. Drug. Deliv"},{"key":"10.1016\/j.addr.2020.09.002_bb0495","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.ijpharm.2011.01.024","article-title":"Deposition of aerosols delivered by nasal route with jet and mesh nebulizers","volume":"407","author":"Vecellio","year":"2011","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.addr.2020.09.002_bb0500","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1089\/jam.2004.17.249","article-title":"Bi-directional nasal delivery of aerosols can prevent lung deposition","volume":"3","author":"Djupesland","year":"2004","journal-title":"J. Aerosol. Med."},{"key":"10.1016\/j.addr.2020.09.002_bb0505","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1097\/01.MLG.0000199741.08517.99","article-title":"T, Holand, breath actuated device improves delivery to target sites beyond the nasal valve","volume":"3","author":"Djupesland","year":"2006","journal-title":"Laryngoscope"},{"key":"10.1016\/j.addr.2020.09.002_bb0510","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.ijpharm.2012.04.023","article-title":"Pulmonary and nasal deposition of ketorolac tromethamine solution (SPRIX) following intranasal administration","volume":"431","author":"Bacon","year":"2012","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.addr.2020.09.002_bb0515","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0074991","article-title":"Topical drug delivery in chronic rhinosinusitis patients before and after sinus surgery using pulsating aerosols","volume":"8","author":"M\u00f6ller","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.addr.2020.09.002_bb0520","doi-asserted-by":"crossref","first-page":"850","DOI":"10.4187\/respcare.03537","article-title":"Imaging in aerosol medicine","volume":"60","author":"Corcoran","year":"2015","journal-title":"Respir. Care"},{"key":"10.1016\/j.addr.2020.09.002_bb0525","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1097\/MNM.0b013e32832c32b3","article-title":"A new method for scintigraphic quantification of deposition and clearance in anatomical regions of the human nose","volume":"30","author":"Skretting","year":"2009","journal-title":"Nucl. Med. Commun."},{"key":"10.1016\/j.addr.2020.09.002_bb0530","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1089\/jam.2006.19.510","article-title":"Validity of in vitro tests on aqueous spray pumps as surrogates for nasal deposition, absorption, and biologic response","volume":"4","author":"Suman","year":"2006","journal-title":"J. Aerosol. Med."},{"key":"10.1016\/j.addr.2020.09.002_bb0535","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1067\/mai.2003.1586","article-title":"Impact of intranasal budesonide on immune inflammatory responses and epithelial remodeling in chronic upper airway inflammation","volume":"112","author":"Mastruzzo","year":"2003","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.addr.2020.09.002_bb0540","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1177\/1945892418810281","article-title":"NAVIGATE I: randomized, placebo-controlled, double-blind trial of the exhalation delivery system with fluticasone for chronic rhinosinusitis with nasal polyps","volume":"33","author":"Sindwani","year":"2019","journal-title":"Am. J. Rhinol. Allergy"},{"key":"10.1016\/j.addr.2020.09.002_bb0545","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.anl.2010.09.001","article-title":"Sinonasal inhalation of dornase alfa in CF: a double-blind placebo-controlled cross-over pilot trial","volume":"38","author":"Mainz","year":"2011","journal-title":"Auris Nasus Larynx"},{"key":"10.1016\/j.addr.2020.09.002_bb0550","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1210\/jc.2017-01976","article-title":"Dose-dependent effects of intranasal insulin on resting-state brain activity","volume":"103","author":"Kullmann","year":"2018","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.addr.2020.09.002_bb0555","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1111\/head.13309","article-title":"DFN-02 (Sumatriptan 10 mg with a permeation enhancer) nasal spray vs placebo in the acute treatment of migraine: a double-blind, placebo-controlled study","volume":"58","author":"Lipton","year":"2018","journal-title":"Headache"},{"key":"10.1016\/j.addr.2020.09.002_bb0560","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1183\/09031936.93.04060694","article-title":"Particle deposition and resistance in the noses of adults and children","volume":"4","author":"Becquemin","year":"1991","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.addr.2020.09.002_bb0565","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1089\/jamp.2018.1476","article-title":"Intranasal filtration of inhaled aerosol in human subjects as a function of nasal pressure drop","volume":"32","author":"Golshahi","year":"2019","journal-title":"J. Aerosol Med. Pulm. Drug Deliv."},{"key":"10.1016\/j.addr.2020.09.002_bb0570","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1080\/02786820300906","article-title":"Aerosol deposition in the Extrathoracic region","volume":"37","author":"Cheng","year":"2003","journal-title":"Aerosol Sci. Technol."},{"key":"10.1016\/j.addr.2020.09.002_bb0575","first-page":"21","article-title":"Drug delivery to the nasal cavity: in vitro and in vivo assessment","volume":"21","author":"Newman","year":"2004","journal-title":"Drug Carrier Syst."},{"key":"10.1016\/j.addr.2020.09.002_bb0580","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1023\/A:1011933410898","article-title":"Comparison of nasal deposition and clearance of aerosol generated by nebulizer and an aqueous spray pump","volume":"16","author":"Suman","year":"1999","journal-title":"Pharm. Res."},{"key":"10.1016\/j.addr.2020.09.002_bb0585","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1177\/0194599818795852","article-title":"Lidocaine\/phenylephrine nasal spray versus nebulization prior to nasoendoscopy: a randomized controlled trial","volume":"159","author":"Goh","year":"2018","journal-title":"Otolaryngol. Head Neck Surg."},{"key":"10.1016\/j.addr.2020.09.002_bb0590","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1007\/s12070-013-0625-y","article-title":"Treatment of chronic rhinosinusitis with pressure-pulsed corticosteroid inhalation","volume":"65","author":"Goektas","year":"2013","journal-title":"Indian J. Otolaryngol. Head Neck Surg."},{"key":"10.1016\/j.addr.2020.09.002_bb0595","first-page":"92","article-title":"Nebulized bacitracin\/colimycin: a treatment option in recalcitrant chronic rhinosinusitis with Staphylococcus aureus? A double-blind, randomized, placebo-controlled, cross-over pilot study","volume":"46","author":"Videler","year":"2008","journal-title":"Rhinology"},{"key":"10.1016\/j.addr.2020.09.002_bb0600","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1016\/j.otohns.2005.08.024","article-title":"Sinonasal distribution of topically applied particles: computerized tomographic detection and the effects of topical decongestion","volume":"133","author":"Senocak","year":"2005","journal-title":"Otolaryngol. Head Neck Surg."},{"key":"10.1016\/j.addr.2020.09.002_bb0605","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1046\/j.1365-2273.1998.2360560.x","article-title":"An endoscopic photographic comparison of nasal drug delivery by aqueous spray","volume":"33","author":"Homer","year":"1998","journal-title":"Clin. Otolaryngol. Allied Sci."},{"key":"10.1016\/j.addr.2020.09.002_bb0610","doi-asserted-by":"crossref","DOI":"10.1002\/cnm.2968","article-title":"Regional deposition of nasal sprays in adults: a wide ranging computational study","volume":"34","author":"Kiaee","year":"2018","journal-title":"Int. J. Numer. Method Biomed. Eng."},{"key":"10.1016\/j.addr.2020.09.002_bb0615","doi-asserted-by":"crossref","first-page":"119341","DOI":"10.1016\/j.ijpharm.2020.119341","article-title":"In vitro assessment of an idealized nose for nasal spray testing: comparison with regional deposition in realistic nasal replicas","volume":"582","author":"Chen","year":"2020","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.addr.2020.09.002_bb0620","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1164\/rccm.200410-1414OC","article-title":"Regional lung deposition and bronchodilator response as a function of beta2-agonist particle size","volume":"172","author":"Usmani","year":"2005","journal-title":"Am. J. Respir. Crit. Care Med."}],"container-title":["Advanced Drug Delivery Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169409X20301265?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169409X20301265?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T05:00:12Z","timestamp":1759208412000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0169409X20301265"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":124,"alternative-id":["S0169409X20301265"],"URL":"https:\/\/doi.org\/10.1016\/j.addr.2020.09.002","relation":{},"ISSN":["0169-409X"],"issn-type":[{"value":"0169-409X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In vitro \u2013 in vivo correlation of intranasal drug deposition","name":"articletitle","label":"Article Title"},{"value":"Advanced Drug Delivery Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.addr.2020.09.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}